Abstract
Poor patient adherence to oral contraceptives is the predominant cause of failure of these therapies, leading to unplanned pregnancies that can negatively affect female health worldwide. To improve patient adherence, we developed an oral contraceptive that is administered once a month. Here, we describe the design and report in vivo characterization of a levonorgestrel-releasing gastric resident dosage form in pigs.
| Original language | English (US) |
|---|---|
| Article number | eaay2602 |
| Journal | Science Translational Medicine |
| Volume | 11 |
| Issue number | 521 |
| DOIs | |
| State | Published - Dec 4 2019 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:Copyright © 2019 The Authors.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'A once-a-month oral contraceptive'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS